Newmont Pays Barrick USD 1.95B to Settle Nevada Gold Mines Dispute, Greenlighting North American IPO
Newmont pays Barrick $1.95B to settle all Nevada Gold Mines JV disputes and consent to North American Barrick's NYSE IPO. NEM +7.18%, Barrick (NYSE: B) -6.11% on Aug. 10.
Verizon's August 8 Voice Outage Likely Crossed the FCC Filing Threshold — Here's the Math
Verizon's Aug. 8 voice outage ran roughly 4 hours across major U.S. cities, likely clearing the FCC's 900,000 user-minute reporting bar — the detail weekend coverage missed.
Coca-Cola (KO) Q2 2026: EPS Beats Fifth Straight Quarter, Volume Hits 17-Year High, Guidance Raised
Coca-Cola Q2 2026: comparable EPS $0.97 (+11%) beats for fifth straight quarter; trademark volume +5%, strongest in 17 years; FY2026 guidance raised; stock +26% YTD.
Home Depot (HD) Dividend Raise Slows to 1.3%, Payout Ratio Rises
Home Depot (NYSE: HD) lifted its quarterly dividend by 1.3% in February, the smallest annual increase in the dividend history the company publishes back to 2020
NVIDIA to Invest Up to USD 3 Billion in Stargate Power Developer Lancium, Taking a 20-30% Stake
NVIDIA is investing up to USD 3 billion in Lancium, the Blackstone-backed power developer that fuels the OpenAI-Oracle Stargate campus in Texas, for a stake of up to 30%.
Disney Q3 FY2026: Streaming Profit Doubles to USD 712M, Parks Set Record, Adjusted EPS Beats by 11%
Disney Q3 FY2026 adj. EPS USD 2.06 beat USD 1.86 estimate. Streaming OI doubled to USD 712M; domestic parks surged 27%; DIS shares rose ~3% premarket.
AMD (NASDAQ: AMD) Q2 2026: Data Center Revenue Doubles to $6.7B, Powering Record $11.5B Quarter
AMD reported record Q2 2026 revenue of $11.54B (+50% YoY) as Data Center revenue doubled to $6.7B. Non-GAAP EPS beat at $1.66. Q3 guidance of ~$13B exceeds consensus despite an 8% after-hours selloff.
Merck (MRK) Q2 2026: Keytruda Holds as Terns Deal Charges Sink Reported Profit — Revenue Guidance Raised
Merck Q2 2026 revenue USD 16.6B beat consensus on Keytruda, Winrevair, and Welireg momentum, while the Terns acquisition IPRD charge drove a non-GAAP EPS loss of -USD 0.13.
Palantir (PLTR) Q2 2026: 'Otherworldly' Commercial Demand Drives 93% Revenue Surge and $500M Guidance Raise
Palantir beat Q2 2026 estimates across the board—revenue +93% to $1.94B, US commercial revenue +149% to $764M—and raised full-year guidance to $8.15B, up $490M from prior targets, sending shares +7.7% after hours.
Oracle (ORCL) Locks Pentagon Into $7 Billion, 10-Year Software Deal—What U.S. Investors Need to Know
Oracle (ORCL) won a $7B, 10-year DoD Enterprise Software Agreement on July 23, 2026. The deal saves $441M in taxpayer costs but represents ~1% of Oracle's annual revenue.
AbbVie Q2 2026: SKYRIZI Matches Humira's Historic Peak as Apogee Deal Trims EPS Outlook
AbbVie beat Q2 2026 revenue estimates with USD 16.99B (+10.2%), driven by SKYRIZI matching Humira's all-time quarterly peak at USD 5.5B. Shares fell ~2% after the company trimmed full-year EPS guidance by USD 0.14/share to absorb the pending USD 10.9B Apogee Therapeutics acquisition, expected to close Q3 2026.
Chevron (CVX) Q2 2026: Net Income Surges 384% to $12.1B on Record Production and $104 Oil
Chevron Q2 2026: net income +384% to $12.1B, adj. EPS $6.06 beats $5.57 consensus, record U.S. production 2.077 MBOED, and a 20-year 2.67 GW power deal with Microsoft. Adjusted FCF reached $15.4B in a single quarter.